These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Chung KF; Caramori G; Adcock IM Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399 [TBL] [Abstract][Full Text] [Related]
4. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids. Naedele-Risha R; Dorinsky P; Craig TJ J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039 [TBL] [Abstract][Full Text] [Related]
5. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. Sovani MP; Whale CI; Tattersfield AE Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy of bronchial asthma. Nelson HS Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671 [TBL] [Abstract][Full Text] [Related]
7. Managing symptoms and exacerbations in pediatric asthma. Verberne AA Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102 [TBL] [Abstract][Full Text] [Related]
8. [Long acting beta-2 agonists in the treatment of asthma and their safety]. Türktaş H; Sekerel B; Karakay G; Yildiz F; Yorgancioğlu A Tuberk Toraks; 2011; 59(4):409-15. PubMed ID: 22233316 [TBL] [Abstract][Full Text] [Related]
9. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern? Lipworth BJ Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530 [TBL] [Abstract][Full Text] [Related]
10. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines. Prenner BM Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276 [TBL] [Abstract][Full Text] [Related]
11. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Bartow RA; Brogden RN Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248 [TBL] [Abstract][Full Text] [Related]
12. The use of inhaled formoterol in the treatment of asthma. Berger WE Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [TBL] [Abstract][Full Text] [Related]
13. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma. Fahy JV; Boushey HA Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410 [TBL] [Abstract][Full Text] [Related]
14. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids. Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982 [TBL] [Abstract][Full Text] [Related]
15. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Salpeter SR; Wall AJ; Buckley NS Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343 [TBL] [Abstract][Full Text] [Related]
16. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. Lyseng-Williamson KA; Plosker GL Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627 [TBL] [Abstract][Full Text] [Related]
17. Drugs for asthma. Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Asthma in Adults: A Review. McCracken JL; Veeranki SP; Ameredes BT; Calhoun WJ JAMA; 2017 Jul; 318(3):279-290. PubMed ID: 28719697 [TBL] [Abstract][Full Text] [Related]
19. Benefit-risk assessment of long-acting beta2-agonists in asthma. Jackson CM; Lipworth B Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic interventions to reduce the risk of asthma exacerbations. O'Byrne PM Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]